This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aardal, S., and Helle, K.B., 1992, The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence from extracellular calcium in isolated segments ofhuman blood vessels. Regul. Pept. 41: 9–18.
Aardal, S., Helle, K.B., Elsayed, S., Reed, R.K., and Serck-Hanssen, G., 1993, Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J. Neuroendocr. 5: 405–412.
Adams, L.A., Ang, L.C., and Muñoz, D.G., 1993, Chromogranin A, a soluble synaptic vesicle protein, is found in cortical neurons other than previously defined peptidergic neurons in the human neocortex. BrainRes. 602: 336–341.
Anker, S.D., Egerer, K.R., Volk, H.D., Kox, W.J., Poole-Wilson, P.A., and Coats, A.J., 1997, Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am. J. Cardiol. 79: 1426–1430.
Bozkurt, B., Kribbs, S.B., Clubb, F.J., Jr., Michael, L.H., Didenko, V.V., Hornsby, P.J., Seta, Y., Oral, H., Spinale, F.G., and Mann, D.L., 1998, Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97: 1382–1391.
Bristow, M.R., 1998, Tumor necrosis factor-alpha and cardiomyopathy. Circulation 97:1340–1341.
Bryant, D., Becker, L., Richardson, J., Shelton, J., Franco, F., Peshock, R., Thompson, M. and Giroir, B., 1998, Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97: 1375–1381.
Ceconi, C., Ferrari, R., Bachetti, T., Giordano, A., Tavazzi, L., Colombo, B., Parrinello, G., and Corti, A., 2000, Chromogranin A in chronic heart failure submitted for publication.
Ciesielski-Treska, J., Ulrich, G., Taupenot, L., Chasserot-Golaz, S., Corti, A., Aunis, D., and Bader, M.F., 1998, Chromogranin A induces a neurotoxic phenotype in brain microglial cells. J.Biol. Chem. 273: 14339–14346.
Cohn, D.V., Zangerle, R., Fischer-Colbrie, R., Chu, L.L., Elting, J.J., Hamilton, J.W., and Winkler, H., 1982, Similarity of secretory protein I from parathyroid gland to chromogranin A from adrenal medulla. Proc. Natl Acad. Sci. USA 79: 6056–6059.
Corti, A., Longhi, R., Gasparri, A., Chen, F., Pelagi, M., and Siccardi, A.G., 1996, Antigenic regions of human chromogranin A and their topographic relationships with structural/functional domains. Eur. J. Biochem. 235: 275–280.
Corti, A., Poiesi, C., Merli, S., and Cassani, G., 1994, Tumor necrosis factor (TNF) alpha quantification by ELISA and bioassay: effects of TNF alpha-soluble TNF receptor (p55) complex dissociation during assay incubations. J.Immnunol. Meth. 177: 191–198.
Deftos, L.J., 1991, Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr. Rev. 12: 181–187.
Ehrhart, M., Jorns, A., Grube, D., and Gratzl, M., 1988, Cellular distribution and amount of chromogranin A in bovine endocrine pancreas. J. Histochem. Cytochem. 36: 467472.
Eichenholz, P.W., Eichacker, P.Q., Hoffman, W.D., Banks, S.M., Parrillo, J.E., Danner, R.L., and Natanson, C., 1992, Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am. J. Physiol. 263: H668–675.
Ferrari, R., Bachetti, T., Confortini, R., Opasich, C., Febo, O., Corti, A., Cassani, G., and Visioli, O., 1995a, Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92: 1479–1486.
Ferrari, R., Corti, A., and Bachetti, T., 1995b, Tumor necrosis factor alpha in heart failure. Heart Failure 11.
Fiers, W., 1995, Biologic therapy with TNF: preclinical studies. In Biologic therapy ofcancer: principles and practice (V. De Vita, S. Hellman and S. Rosenberg, eds.), J.B. Lippincott Company, Philadelphia, pp. 295–327
Gasparri, A., Sidoli, A., Sanchez, L.P., Longhi, R., Siccardi, A.G., Marchisio, P.C., and Corti, A., 1997, Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain. J. Biol. Chem. 272: 20835–20843.
Hegewisch, S., Weh, H.J., and Hossfeld, D.K., 1990, TNF-induced cardiomyopathy. Lancet 335: 294–295.
Helle, K.B., Marley, P.D., Angeletti, R.H., Aunis, D., Galindo, E., Small, D.H., and Livett, B.G., 1993, Chromogranin A: secretion of processed products from the stimulated retrogradely perfused bovine adrenal gland. J. Neuroendocr. 5: 413420.
Kapadia, S., Dibbs, Z., Kurrelmeyer, K., Kalra, D., Seta, Y., Wang, F., Bozkurt, B., Oral, H., Sivasubramanian, N., and Mann, D.L., 1998, The role of cytokines in the failing human heart. Cardiol. Clin. 16: 645–656.
Kubota, T., McTieman, C.F., Frye, C.S., Slawson, S.E., Lemster, B.H., Koretsky, A.P., Demetris, A.J., and Feldman, A.M., 1997, Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression oftumor necrosis factor-alpha. Circ. Res. 81: 627–635.
Levine, B., Kalman, J., Mayer, L., Fillit, H.M., and Packer, M., 1990, Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl. J. Med. 323: 236–241.
Lo, S.K., Everitt, J., Gu, J., and Malik, A.B., 1992, Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J. Clin. Invest. 89: 981–988.
MacGowan, G.A., Mann, D.L., Kormos, R.L., Feldman, A.M., and Murali, S., 1997, Circulating interleukin-6 in severe heart failure. Am. J. Cardiol. 79: 1 128–1 131.
Mahata, S.K., OConnor, D.T., Mahata, M., Yoo, S.H., Taupenot, L., Wu, H., Gill, B.M., and Parmer, R.J., 1997, Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J. Clin. Invest. 100: 1623–1633.
Mann, D.L., 1996, The effect of tumor necrosis factor-alpha on cardiac structure and function: a tale of two cytokines. J. Card. Failure 2: S165–172.
Mann, D.L., Jackson, D.L., and Yokoyama, M.D., 1995, Tumor Necrosis Factor alpha and cardiac remodelling. HeartFailure 11: 166–176.
Muñoz, D.G., Kobylinski, L., Henry, D.D., and George, D.H., 1990, Chromogranin A-like immunoreactivity in the human brain: distribution in bulbar medulla and cerebral cortex. Neuroscience 34: 533–543.
Nicholls, D.P., Onuoha, G.N., McDowell, G., Elborn, J.S., Riley, M.S., Nugent, A.M., Steele, I.C., Shaw, C., and Buchanan, K.D., 1996, Neuroendocrine changes in chronic cardiac failure. Basic Res. Cardiol. 91: 13–20.
OConnor, D.T., Parmer, R.J., and Deftos, L.J., 1984, Chromogranin A: studies in the endocrine system. Transact.Ass. Am. Physic. 97: 242–250.
Qian, J., Hickey, W.F., and Angeletti, R.H., 1988, Neuroendocrine cells in intestinal lamina propria. Detection with antibodies to chromogranin A. J. Neuroimmunol. 17: 159–165.
Rosa, P., and Gerdes, H.H., 1994, The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors. J. Endocr. Invest. 17: 207–225.
Serck-Hanssen, G., and O’Connor, D.T., 1984, Immunological identification and characterization of chromogranins coded by poly(A) mRNA from bovine adrenal medulla and pituitary gland and human phaeochromocytoma. J. Biol. Chem. 259: 11597–11600.
Simon, J.P., and Aunis, D., 1989, Biochemistry of the chromogranin A protein family. Biochem. J. 262: 1–13.
Soriano, J.V., Pepper, M.S., Taupenot, L., Bader, M.F., Orci, L., and Montesano, R., 1999, Chromogranin A alters ductal morphogenesis and increases deposition of basement membrane components by mammary epithelial cells in vitro. Biochem. Biophys. Res. Comm. 259: 563–568.
Tatemoto, K., Efendic, S., Mutt, V., Makk, G., Feistner, G.J., and Barchas, J.D., 1986, Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature (London) 324: 476–478.
Torre-Amione, G., Bozkurt, B., Deswal, A., and Mann, D.L., 1999, An overview of tumor necrosis factor alpha and the failing human heart. Curr. Opin. Cardiol., 14: 206–210.
Torre-Amione, G., Kapadia, S., Lee, J., Bies, R.D., Lebovitz, R., and Mann, D.L., 1995, Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 92: 1487–1493.
Torre-Amione, G., Kapadia, S., Lee, J., Durand, J.B., Bies, R.D., Young, J.B., and Mann, D.L., 1996, Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93: 704–711.
Vandenabeele, P., Declercq, W., Beyaert, R., and Fiers, W., 1995, Two tumor necrosis factor receptors: structure and function. Trends Cell. Biol. 5: 392–399.
Weber, K.T., 1997, Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation 96: 4065–4082.
Winkler, H., and Fischer-Colbrie, R., 1992, The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49: 497–528.
Yokoyama, T., Vaca, L., Rossen, R.D., Durante, W., Hazarika, P., and Mann, D.L., 1993, Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J. Clin. Invest. 92: 2303–2312.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Corti, A., Ferrari, R., Ceconi, C. (2002). Chromogranin A and Tumor Necrosis Factor-α (TNF) in Chronic Heart Failure. In: Helle, K.B., Aunis, D. (eds) Chromogranins. Advances in Experimental Medicine and Biology, vol 482. Springer, Boston, MA. https://doi.org/10.1007/0-306-46837-9_28
Download citation
DOI: https://doi.org/10.1007/0-306-46837-9_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46446-1
Online ISBN: 978-0-306-46837-7
eBook Packages: Springer Book Archive